Recent studies revealed the expression of PD-L1 among various B-cell lymphomas [4–6] with the most remarkable therapeutic benefits of PD-1 blockade in patients with Hodgkin lymphoma [3, 7]. The gene discussed is CD274; the disease is B-cell non-Hodgkin lymphoma.